Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, China.
Department of Pulmonary Diseases, Wuxi Infectious Diseases Hospital, 1215 Guangrui Road, Wuxi, 214005, China.
BMC Infect Dis. 2022 Jun 14;22(1):543. doi: 10.1186/s12879-022-07506-z.
Immune checkpoints are crucial for the maintenance of subtle balance between self-tolerance and effector immune responses, but the role of soluble immune checkpoints (sICs) in Mycobacterium tuberculosis (M. tb) infection remains unknown. We assessed the levels of multiple sICs in individuals with distinct M. tb infection status, and their dynamic changes during anti-tuberculosis treatment.
We enrolled 24 patients with pulmonary tuberculosis, among which 10 patients were diagnosed with tuberculous pleurisy (TBP), 10 individuals with latent tuberculosis infection (LTBI), and 10 healthy volunteers from Wuxi Fifth People's Hospital and Huashan Hospital between February 2019 and May 2021. Plasma concentrations of thirteen sICs were measured at enrollment and during anti-tuberculosis treatment using luminex-based multiplex assay. sICs levels in tuberculous pleural effusion (TPE) and their relations to laboratory test markers of TPE were also assessed in TBP patients.
The circulating levels of sPD-1, sPD-L1, sCTLA-4, sBTLA, sGITR, sIDO, sCD28, sCD27 and s4-1BB were upregulated in tuberculosis patients than in healthy controls. A lower sPD-L1 level was found in LTBI individuals than in tuberculosis patients. In TBP patients, the levels of sPD-1, sPD-L2, sCD28, sCD80, sCD27, sTIM-3, sLAG-3, sBTLA, s4-1BB and sIDO increased significantly in TPE than in plasma. In TPE, sBTLA and sLAG-3 correlated positively with the adenosine deaminase level. sIDO and sCD80 correlated positively with the lactate dehydrogenase level and the percentage of lymphocytes in TPE, respectively. Meanwhile, sCD27 correlated negatively with the specific gravity and protein level in TPE. In tuberculosis patients, the circulating levels of sBTLA and sPD-L1 gradually declined during anti-tuberculosis treatment.
We characterized the changing balance of sICs in M. tb infection. And our results revealed the relations of sICs to laboratory test markers and treatment responses in tuberculosis patients, indicating that certain sICs may serve as potential biomarkers for disease surveillance and prognosis of tuberculosis.
免疫检查点对于维持自身耐受和效应免疫反应之间的微妙平衡至关重要,但可溶性免疫检查点(sICs)在结核分枝杆菌(M. tb)感染中的作用尚不清楚。我们评估了不同 M. tb 感染状态个体的多种 sIC 水平,并在抗结核治疗期间评估了它们的动态变化。
我们招募了 24 名肺结核患者,其中 10 名患者被诊断为结核性胸膜炎(TBP),10 名个体为潜伏性结核感染(LTBI),10 名健康志愿者来自无锡第五人民医院和华山医院,时间为 2019 年 2 月至 2021 年 5 月。使用基于 Luminex 的多重分析在入组时和抗结核治疗期间测量了 13 种 sIC 的血浆浓度。还评估了 TBP 患者结核性胸腔积液(TPE)中的 sIC 水平及其与 TPE 实验室检测标志物的关系。
与健康对照相比,结核患者的循环 sPD-1、sPD-L1、sCTLA-4、sBTLA、sGITR、sIDO、sCD28、sCD27 和 s4-1BB 水平上调。LTBI 个体的 sPD-L1 水平低于结核患者。在 TBP 患者中,与血浆相比,TPE 中的 sPD-1、sPD-L2、sCD28、sCD80、sCD27、sTIM-3、sLAG-3、sBTLA、s4-1BB 和 sIDO 水平显着升高。在 TPE 中,sBTLA 和 sLAG-3 与腺苷脱氨酶水平呈正相关。sIDO 和 sCD80 分别与 TPE 中的乳酸脱氢酶水平和淋巴细胞百分比呈正相关。同时,sCD27 与 TPE 的比重和蛋白水平呈负相关。在结核患者中,循环 sBTLA 和 sPD-L1 水平在抗结核治疗过程中逐渐下降。
我们描述了 M. tb 感染中 sIC 变化平衡。我们的结果揭示了 sICs 与结核患者实验室检测标志物和治疗反应的关系,表明某些 sICs 可能作为疾病监测和结核病预后的潜在生物标志物。